| Studies | Sample (t/c) | Diagnosis standard | Age | Intervention group | Control group | Course (day) | Outcome measures |
| Guo 2007 [25] | 20/16 | ISFC/WHO | 59 ± 6.7 | Ligustrazine injection, nitrates, aspirin, ACE inhibitor | Nitrates, aspirin, ACE inhibitor | 14 | IAS, NIWAS, IECG, NIWECG |
|
Liao and Luo 2006 [26] | 34/34 | ISFC/WHO | 46–71 | Ligustrazine injection, nitrates, aspirin | Nitrates and aspirin | 15 | IAS and NIWAS |
| Da 2008 [27] | 38/36 | CSC | 41–83 | Ligustrazine injection, nitrates, aspirin, Low Molecular Weight Heparin (LMWH), beta blockers | Nitroglycerin, aspirin, LMWH, beta blockers | 14 | IAS, NIWAS, IECG, NIWECG |
|
Rong et al. 2001 [28] | 32/32 | Other | 64.3 ± 7.2 | Ligustrazine injection, nitrates, aspirin | Nitrates and aspirin | 10 | IAS and NIWAS |
| Peng 2014 [29] | 43/42 | CSC | 61.2 ± 5.94 | Ligustrazine injection, nitrates, antiplatelet drugs | Nitrates and antiplatelet drugs | 14 | IAS, NIWAS, IECG, NIWECG, AOT, SF, RNU, FIB |
|
Wang and Hua 2004 [30] | 30/28 | ISFC/WHO | Unclear | Ligustrazine injection, beta blockers, aspirin, calcium channel blockers (CCB), LMWH, ACE inhibitor | Beta blockers, aspirin, CCB, LMWH, ACE inhibitor | 28 | IAS and NIWAS |
|
Wei et al. 2012 [31] | 60/60 | CSC | 48–79 | Ligustrazine injection, antiplatelet drugs, nitrates, beta blockers | Antiplatelet drugs, nitrates, beta blockers | 14 | IAS, NIWAS, AOT, SF, FIB |
| Wang 2006 [32] | 65/65 | CSC | 67.5 ± 9 | Ligustrazine injection, beta blockers, nitrates, aspirin, CCB, ACE inhibitor | Beta blockers, nitrates, aspirin, CCB, ACE inhibitor | 14 | IAS and NIWAS |
| Zhou 2008 [33] | 78/50 | ISFC/WHO | 39–89 | Ligustrazine injection, nitroglycerin, aspirin, CCB, beta blockers | Nitroglycerin, aspirin, CCB, beta blockers | 14 | IAS and NIWAS |
| Li 2010 [34] | 38/30 | Other | 42–76 | Ligustrazine injection, nitroglycerin, aspirin, LMWH, beta blockers | Nitroglycerin, aspirin, LMWH, beta blockers | 14 | IAS and NIWAS |
| Sun 2007 [35] | 48/48 | Other | 48–80 | Ligustrazine injection, nitrates, aspirin, beta blockers, statins, ACE inhibitor | Nitrates, aspirin, beta blockers, statins, ACE inhibitor | 21 | IAS, NIWAS, IECG, NIWECG, FIB |
| Wang 2008 [36] | 42/42 | ISFC/WHO | 48–78 | Ligustrazine injection, nitrates, aspirin, beta blockers, CCB, statins, ACE inhibitor | Nitrates, aspirin, beta blockers, CCB, statins, ACE inhibitor | 14 | IAS, NIWAS, IECG, NIWECG |
| Fan 2014 [37] | 63/63 | Other | 73.5 ± 12.6 | Ligustrazine injection, nitrates, aspirin, statins | Nitrates, aspirin, statins, beta blockers | 14 | IAS, NIWAS, IECG, NIWECG, AOT, SF, RNU |
|
Fu and Lin 2009 [38] | 40/41 | Other | Unclear | Ligustrazine injection, nitrates, aspirin, statins, LMWH, beta blockers | Nitrates, aspirin, statins, LMWH, beta blockers | 14 | IAS and NIWAS |
|
Meng et al. 2005 [39] | 38/38 | ISFC/WHO | 68.8 ± 7.8 | Ligustrazine injection, nitrates, beta blockers, ACE inhibitor, CCB, LMWH | Nitrates, beta blockers, ACE inhibitor, CCB, LMWH | 10 | IAS, NIWAS, IECG, NIWECG, FIB, CEs |
|
Wang et al. 2005 [40] | 32/30 | ISFC/WHO | 50–66 | Ligustrazine injection, nitrates, aspirin, LMWH, beta blockers | Nitrates, aspirin, LMWH, beta blockers | 14 | IAS, NIWAS, IECG, NIWECG |
|
|